Tilray Brands Inc (TLRY)
1.75
-0.09
(-4.89%)
USD |
NASDAQ |
Apr 25, 16:00
1.745
0.00 (0.00%)
After-Hours: 20:00
Tilray Brands SG&A Expense (Quarterly): 61.10M for Feb. 29, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 61.10M |
November 30, 2023 | 60.13M |
August 31, 2023 | 55.91M |
May 31, 2023 | 64.67M |
February 28, 2023 | 52.82M |
November 30, 2022 | 56.15M |
August 31, 2022 | 57.35M |
May 31, 2022 | 61.86M |
February 28, 2022 | 59.56M |
November 30, 2021 | 49.60M |
August 31, 2021 | 62.36M |
May 31, 2021 | 46.47M |
February 28, 2021 | 33.90M |
November 30, 2020 | 38.60M |
August 31, 2020 | 36.71M |
May 31, 2020 | 40.82M |
February 29, 2020 | 31.59M |
November 30, 2019 | 31.52M |
August 31, 2019 | 26.24M |
May 31, 2019 | 31.13M |
February 28, 2019 | 33.23M |
November 30, 2018 | 17.46M |
August 31, 2018 | 15.18M |
May 31, 2018 | 14.34M |
February 28, 2018 | 9.193M |
Date | Value |
---|---|
November 30, 2017 | 5.433M |
August 31, 2017 | 4.905M |
May 31, 2017 | 2.482M |
February 28, 2017 | 3.292M |
November 30, 2016 | 2.452M |
August 31, 2016 | 1.943M |
May 31, 2016 | 1.626M |
February 29, 2016 | 1.302M |
November 30, 2015 | 1.26M |
August 31, 2015 | 0.8206M |
May 31, 2015 | 0.8662M |
February 28, 2015 | 2.725M |
November 30, 2014 | 0.0065M |
August 31, 2014 | -0.0026M |
May 31, 2014 | 0.0633M |
February 28, 2014 | 0.0472M |
November 30, 2013 | 0.0046M |
August 31, 2013 | 0.0079M |
May 31, 2013 | 0.0045M |
February 28, 2013 | 0.0133M |
November 30, 2012 | 0.0205M |
August 31, 2012 | 0.0137M |
May 31, 2012 | 0.018M |
February 29, 2012 | 0.0657M |
November 30, 2011 | 0.0034M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
26.24M
Minimum
Aug 2019
64.67M
Maximum
May 2023
47.93M
Average
51.21M
Median
SG&A Expense (Quarterly) Benchmarks
Clever Leaves Holdings Inc | 4.102M |
Flora Growth Corp | 5.581M |
Acasti Pharma Inc | 1.60M |
Aurinia Pharmaceuticals Inc | 50.07M |
Edesa Biotech Inc | 1.153M |